On November 8, during the 3rd CIIE, SANSURE BIOTECH INC. and the world leader in scientific services, Thermo Fisher Scientific (China) ) Co., Ltd. ("Thermo Scientific"), signed a memorandum of strategic partnership.

Strategic cooperation of IVD companies in the 3rd CIIE: KingMed Diagnostics and Danaher Diagnostics platform signed a strategic cooperation agreement; Roche Diagnostics and GE Healthcare signed a memorandum of strategic cooperation at the CIIE.

BSL-P2+, a mobile lab vehicle developed by Shanghai Experimental Medicine Academy and related technological enterprise officially appears on the 3rd CIIE (China International Import Expo).

On November 3, COVID-19 (2019-NCOV) antigen detection kit (Colloidal Gold method) and COVID-19 (2019-NCOV) antigen detection kit (Latex method) were approved by China National Medical Products Administration.

The prevention and control of the epidemic now requires a rapid detection method suitable for the grassroots.

Recently, a number of IVD companies reached cooperation.

Chairman of CAIVD, Mr. Song Haibo invited by Weimi Bio on Oct. 22nd to guide the work.

On October 26, Chemclin Diagnostics Corporation delivered the good news that it will be listed on the Sci-Tech innovation board in the IPO meeting.

In the clinical application of POCT more and more widely today, how to strengthen the quality management, avoid the management "blind area" and other issues, after hot discussion and practical exploration, has shown positive results and experience.

On October 20, 2020, Jiangsu Bioperfectus technologies Co., Ltd. and IntelliBio had reached a strategic cooperation. The two sides will work together to build intelligent solutions.

Recently, the centers for disease control and prevention in Africa and the African union commission jointly launched a Pathogen genome project (Pathogen Genomics Initiative, PGI).

On Oct. 20th, the Hurun Research Institute released the Hurun China Rich List 2020 a ranking of the richest individuals in China, with a wealth cut-off of CNY 2 billion, equivalent to US$290 million. Wealth calculations are from 28 August.

Reported by CCTV news on Oct. 16th, variety of countries need to enlarge the test method to speed up the diagnosis on COVID-19.

Mindray is expected to achieve the operating income of 14.855 billion yuan to 16.093 billion yuan in the first three quarters of 2020, a year-on-year growth of 20% to 30%.

On Sep. 25th, Upper Biotech applied for IPO was accepted by Shanghai Stock Exchange. At present, it has 7 listed enterprise on STAR Market, 2 registered upcoming companies and 5 waitings.